BioPharm International-10-15-2015

BioPharm International eBooks

Can alternative approaches to the permitted/acceptable daily exposure be justified?

BioPharm International eBooksVolume 28, Issue 14 Single-use technologies including polymer film bags, tubing, filter capsules, and appropriate connectors have become widely accepted in bioprocessing of proteins and vaccines.

Isolators offer a safety and economic advantage for next-generation regenerative medicine products.

This article examines trends in biopharma post-grant patent review and projects what the future holds in store.

This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.

How can the industry achieve excellence when its training programs are geared to meeting minimum regulatory guidelines?